Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymphomas in immunocompromised hosts]

F Berger1, H J Delecluse

  • 1Laboratoire d'anatomie pathologique, hôpital Edouard-Herriot, Lyon.

La Revue Du Praticien
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robotic-assisted partial nephrectomy (RAPN) and standardization of outcome reporting: a prospective, observational study on reaching the "Trifecta and Pentafecta".

Journal of robotic surgery·2020
Same author

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer.

Oncoimmunology·2019
Same author

Metabolomics as read-across tool: An example with 3-aminopropanol and 2-aminoethanol.

Regulatory toxicology and pharmacology : RTP·2019
Same author

Publisher Correction: Model-Based Therapy Planning Allows Prediction of Haemodynamic Outcome after Aortic Valve Replacement.

Scientific reports·2019
Same author

Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.

Current microbiology·2019
Same author

Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter "CASPED" study.

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Immunodeficiency increases the risk of B-cell lymphoproliferations, often linked to Epstein-Barr virus (EBV). Understanding EBV

Area of Science:

  • Immunology
  • Virology
  • Oncology

Context:

  • Immunodeficiency states, both congenital and acquired, are linked to a higher incidence of lymphoproliferative disorders.
  • The increasing prevalence of organ transplantation and Human Immunodeficiency Virus (HIV) infection contributes to the rising incidence of these conditions.
  • Epstein-Barr virus (EBV) plays a significant role in the pathogenesis of many of these B-cell lymphoproliferations.

Purpose:

  • To explore the association between immunodeficiency, Epstein-Barr virus (EBV), and the development of B-cell lymphoproliferations.
  • To examine the mechanisms by which EBV contributes to lymphomagenesis in immunocompromised individuals.
  • To discuss the clinical and biological factors influencing the prognosis and management of these disorders.

Summary:

Related Experiment Videos

  • Lymphoproliferative disorders in immunocompromised individuals are predominantly B-cell in origin, frequently extranodal, and commonly associated with EBV.
  • EBV's ability to immortalize B lymphocytes and the compromised T-cell immunity in certain conditions (e.g., X-linked lymphoproliferative syndrome, post-transplant, HIV/AIDS) facilitate uncontrolled B-cell proliferation.
  • Management requires a combined biological and clinical approach to assess tumor aggressiveness and host immune response, with reduction of immunosuppression sometimes leading to regression.

Impact:

  • These lymphoproliferations serve as a crucial model for understanding the complex interplay between EBV and the immune system.
  • Insights gained can inform diagnostic and therapeutic strategies for EBV-associated malignancies in immunocompromised populations.
  • Highlights the importance of immune surveillance in controlling EBV-driven B-cell proliferation.